Thrombocytopenia, characterized by abnormally low platelet counts in circulating blood, is caused by decreased platelet production and/or accelerated platelet destruction [1]. The main concept in treating thrombocytopenia is to eliminate the cause of the accelerated platelet destruction or increase platelet counts by stimulating the production of new platelets [2]. Thrombopoietin receptor (TPOR) is recognized as an ideal target for the treatment of thrombocytopenia [3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile